Implications of Diabetes Mellitus in Patients with Acute Coronary Syndromes - Poorer Outcomes Among Diabetics

1. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? Stephens JW, Ambler G, Vallance P, Betteridge DJ, Humphries SE, Hurel SJ., Eur J Cardiovasc Prev Rehabil 2004; 11:521528.10.1097/00149831-200412000-00013Search in Google Scholar

2. Cardiovascular risk assessment and screening in diabetes., Zhao, Yanglu, Cardiovascular Endocrinology & Metabolism: March 2017 - Volume 6 - Issue 1 - p 172210.1097/XCE.0000000000000115676852531646114Search in Google Scholar

3. Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives, Ryo Naito and Takatoshi Kasai, World J Cardiol. 2015 Mar 26; 7(3): 119124., 2015 Mar 26.10.4330/wjc.v7.i3.119436530825810811Search in Google Scholar

4. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus. Echouffo-Tcheugui JB, Kengne AP. Diabetes Metab 2013; 39:389396.10.1016/j.diabet.2013.07.002Search in Google Scholar

5. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr, Gibbons R, et al., J Am Coll Cardiol 2014; 63 (Pt B):29352959.Search in Google Scholar

6. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. K P Morgan, A Kapur, and K J Beatt, Heart. 2004 Jul; 90(7): 732738.10.1136/hrt.2003.021014176832615201238Search in Google Scholar

7. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology, Tullio Palmerini Diego Sangiorgi Antonio Marzocchi, European Heart Journal Volume 30 Issue 17 September 2009)10.1093/eurheartj/ehp22319508996Search in Google Scholar

8. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials, Jay S. Skyler, MD, MACP1, Richard Bergenstal, MD2, Robert O. Bonow,Journal of the American College of Cardiology, Volume 53, Issue 3, January 200910.1016/j.jacc.2008.10.00819147051Search in Google Scholar

9. Optimal medical therapy with or without PCI for stable coronary disease. Boden WE, O’Rourke RA, COURAGE Trial Research Group. N Engl J Med. 2007; 356: 15031516. doi: 10.1056/NEJMoa07082910.1056/NEJMoa07082917387127Search in Google Scholar

10. A randomized trial of therapies for type 2 diabetes and coronary artery disease. The BARI 2D Study Group, Frye RL, N Engl J Med. 2009;360:25032515.10.1056/NEJMoa0805796Search in Google Scholar

11. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Kappetein AP, Head SJ, SYNTAX Investigators. Eur J Cardiothorac Surg. 2013;43:10061013. doi: 10.1093/ejcts/ezt01710.1093/ejcts/ezt01723413014Search in Google Scholar

12. Strategies for multivessel revascularization in patients with diabetes. Farkouh ME, Domanski M, FREEDOM Trial Investigators N Engl J Med. 2012;367:23752384. doi: 10.1056/NEJMoa121158510.1056/NEJMoa121158523121323Search in Google Scholar

13. Strategies for multivessel revascularization in patients with diabetes Farkouh ME, Domanski M, FREEDOM Trial Investigators. N Engl J Med. 2012;367:23752384. doi: 10.1056/NEJMoa1211585.10.1056/NEJMoa1211585Search in Google Scholar

14. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: Can newer generation drug-eluting stents bridge the gap? Bangalore S, Circ Cardiovasc Interv. 2014;7:182510.1161/CIRCINTERVENTIONS.114.00134624939927Search in Google Scholar

15. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. Généreux P, Madhavan MV, Mintz GS, J Am Coll Cardiol. 2014;63:18451854. doi: 10.1016/j.jacc.2014.01.034.10.1016/j.jacc.2014.01.03424561145Search in Google Scholar

16. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. K P Morgan, A Kapur, and K J Beatt, Heart. 2004 Jul; 90(7): 732738.10.1136/hrt.2003.021014176832615201238Search in Google Scholar

17. Percutaneous Coronary Interventions in the Diabetic Patient.Where Do We Stand? John A. Bittl, Circulation: Cardiovascular Interventions. 2015;8:e00194410.1161/CIRCINTERVENTIONS.114.00194425788342Search in Google Scholar

18. Coronary artery disease and diabetes mellitus, Doron Aronson, MD* and Elazer R. Edelman, MD, PhD, Cardiol Clin. 2014 Aug; 32(3): 439455. 2014 Jun 10.10.1016/j.ccl.2014.04.001467294525091969Search in Google Scholar

19. Angiographic characteristics of the coronary artery in patients with type 2 diabetes. Tong-guo Wu, MD1 and Lexin Wang, MD PhD. Exp Clin Cardiol. 2002 Winter; 7(4): 199200.Search in Google Scholar